More than 75,000 cases of eye drops have been voluntarily recalled by a pharmaceutical testing lab after an audit by the Food ...

More than 76,000 eye drops and other eye care products are being voluntarily recalled after an audit by the Food and Drug ...

Recognized among the best kratom brands, this kratom vendor offers lab-tested, AKA-approved kratom products for consumers ...

Over 75,000 bottles of eye drops have been recalled due to FDA audit findings of manufacturing violations, including ...

Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the third ...

Over 75,000 cases of eye drops have been recalled due to sterility concerns, urging consumers to stop using affected products ...

Capsida Biotherapeutics ("Capsida") today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for CAP-002, its wholly owned first-in-class, ...

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics ...

A nationwide recall of 75,000 eye drop products was issued due to FDA safety violations and sterility concerns. Experts ...

A new specialist manufacturing facility in Scotland could soon provide solutions to scaling challenges for vital ...

Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ETCorporate ParticipantsJohn Fraunces - LifeSci Advisors, ...

Columbia University, the Company's collaboration partner for pre-clinical development, granted Silo an exclusive global ...